These differ in their fusion endpoints from the OCLN–RASGRF1 and IQGAP1–RASGRF1 fusions reported here from a cholangiocarcinoma and a melanoma, respectively (although the segment of OCLN in both OCLN–RASGRF1 fusions is the same). This evidence concerns the gene RASGRF1 and cholangiocarcinoma.